Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

YKL-39 Activators

Chemical classes known as YKL-39 activators encompass a range of compounds that interact with biological pathways, resulting in the upregulation of the YKL-39 protein. These activators are not unified by a single chemical structure or class, but rather by their ability to engage with various cellular mechanisms that lead to an increase in the expression or activity of YKL-39. The pathways involved are diverse, including those that regulate inflammation, cell growth, tissue remodeling, and repair. For instance, certain inhibitors that target growth factor signaling pathways can induce changes in cellular behavior that necessitate the expression of proteins like YKL-39. These proteins may be upregulated as part of a complex response to the altered signaling dynamics, thereby contributing to the cellular adaptation to these changes.

Moreover, compounds that modulate the immune response through different receptors or signaling molecules also play a role in the regulation of proteins such as YKL-39. By influencing the intricate network of cytokines, growth factors, and other signaling entities, these activators can create a cellular environment that favors the expression of YKL-39. This is particularly evident in the context of inflammation and immune responses, where the balance of pro-inflammatory and anti-inflammatory signals can dictate the level of expression of specific proteins involved in these processes. Additionally, molecules that affect the synthesis of components of the extracellular matrix, which provides structural and biochemical support to surrounding cells, can also lead to an increased activity of YKL-39. Through these diverse methods of action, the compounds classified as YKL-39 activators contribute to the modulation of the protein's expression, reflecting the adaptive capacity of cellular systems to environmental and internal cues.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB-431542 inhibits TGF-beta signaling, which is involved in fibrosis and tissue remodeling, processes where YKL-39 could be upregulated.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib blocks PDGF receptors and could influence YKL-39 expression by altering the cellular response to tissue injury and repair.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib inhibits EGF receptors and could impact YKL-39 expression by modulating cell growth and repair mechanisms.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

PD173074 inhibits FGF receptors, which may lead to changes in YKL-39 expression during processes like wound healing and angiogenesis.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Rosiglitazone could modulate inflammation and fibrotic responses, potentially influencing YKL-39 expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Tretinoin, an active metabolite of vitamin A, may alter YKL-39 expression through its role in cell differentiation and growth.

4-Methylumbelliferone

90-33-5sc-206910
sc-206910A
sc-206910B
sc-206910C
sc-206910D
25 g
100 g
250 g
1 kg
2.5 kg
$35.00
$56.00
$141.00
$431.00
$973.00
2
(1)

4-Methylumbelliferone can stimulate the production of hyaluronic acid, which could affect YKL-39 in tissue remodeling.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Lysophosphatidic acid itself, acting through its receptors, could promote cell responses that result in YKL-39 expression changes.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate, through its anti-inflammatory action, might influence the levels of YKL-39 in immune-mediated processes.